Company Filing History:
18 out of 33 
8 out of 4,945 
1 out of 832,843 Years Active: 2006-2012
Title: Helen P. Findlay – Innovator in Cancer Therapeutics
Introduction
Helen P. Findlay is a prominent inventor based in Toronto, Canada, known for her significant contributions to the field of cancer research. With a remarkable portfolio of 26 patents, Findlay has been at the forefront of developing innovative methods and tools to combat cancer, particularly through the production of therapeutic antibodies.
Latest Patents
Among her latest innovations, Findlay's work on cancerous disease-modifying antibodies stands out. This invention involves a groundbreaking method for producing these antibodies utilizing a novel screening paradigm. By focusing on segregating anti-cancer antibodies through cancer cell cytotoxicity as an endpoint, her process enables the creation of antibodies for both therapeutic and diagnostic applications. These antibodies are crucial for the staging and diagnosis of cancer and hold potential in treating primary tumors as well as tumor metastases. Additionally, they can be conjugated with various compounds, including toxins, enzymes, radioactive agents, cytokines, and hematogenous cells, enhancing their effectiveness in cancer therapy.
Career Highlights
Throughout her career, Helen P. Findlay has made significant strides in cancer research and biotechnology. She has worked with esteemed organizations such as Arius Research, Inc. and Hoffmann-La Roche Inc., contributing to the advancement of cancer therapies and diagnostics.
Collaborations
Findlay's work has been further enriched through collaborations with notable professionals in the field, including David S. F. Young and Susan E. Hahn. These partnerships have fostered shared knowledge and innovation, leading to a greater impact in the healthcare domain.
Conclusion
In conclusion, Helen P. Findlay's innovative contributions to cancer research and her extensive patent portfolio underscore her status as a leading inventor in the field. Her dedication to developing novel therapeutic approaches continues to inspire advancements in cancer treatment and diagnosis, making her a key figure in the ongoing battle against this disease.